Heterogeneity in early lesion changes on treatment as a marker of poor prognosis in patients (pts) with metastatic colorectal cancer (mCRC) treated with first line systemic chemotherapy ± biologic: Findings from 9,092 pts in the ARCAD database.

被引：8
|
作者：
Ou, Fang-Shu
Hubbard, Joleen Marie
Kasi, Pashtoon Murtaza
Dixon, Jesse
Van Cutsem, Eric
Saltz, Leonard
Schmoll, Hans-Joachim
Punt, Cornelis J. A.
Goldberg, Richard M.
Paulo
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.3535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3535
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Evaluation of lesion-based response at 12 weeks (LBR12) of treatment (Rx) in metastatic colorectal cancer (mCRC): Findings from 9,092 patients (pts) in the ARCAD database.
    Ou, Fang-Shu
    Lou, Yiyue
    Van Cutsem, Eric
    Saltz, Leonard
    Schmoll, Hans-Joachim
    Goldberg, Richard M.
    Hoff, Paulo
    Douillard, Jean-Yves
    Hecht, J. Randolph
    Hurwitz, Herbert
    Punt, Cornelis J. A.
    Bokemeyer, Carsten
    Fuchs, Charles S.
    Diaz-Rubio, Eduardo
    Tebbut, Niall
    Falcone, Alfredo
    Kabbinavar, Fairooz F.
    De Gramont, Aimery
    Grothey, Axel
    Shi, Qian
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] Associations of incidence of common adverse events (AEs) and survival outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line chemotherapy: Findings from 9,812 pts in the ARCAD database.
    Ferraro, Danielle Angela
    Zalcberg, John Raymond
    Shi, Qian
    Meyers, Jeffrey P.
    Seymour, Matthew T.
    Saltz, Leonard
    Maughan, Tim
    Goldberg, Richard M.
    Van Cutsem, Eric
    Heinemann, Volker
    Hurwitz, Herbert
    Falcone, Alfredo
    Diaz-Rubio, Eduardo
    Chibaudel, Benoist
    Fuchs, Charles S.
    Porschen, Rainer
    Bokemeyer, Carsten
    De Gramont, Aimery
    Price, Tim
    Adams, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [3] Outcomes in the second line treatment of metastatic colorectal cancer (mCRC): Findings from 6,462 patients (pts) in the ARCAD database.
    Leal, Alexis Diane
    Ou, Fang-Shu
    De Gramont, Aimery
    Pederson, Levi
    Sobrero, Alberto F.
    Peeters, Marc
    Arnold, Dirk
    Pitot, Henry C.
    Rothenberg, Mace L.
    Giantonio, Bruce J.
    Van Cutsem, Eric
    Sargent, Daniel J.
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [4] Impact of overall severity of adverse events (AEs) on long-term outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line systemic chemotherapy: Findings from 3,971 pts in the ARCAD database.
    Zalcberg, John Raymond
    Shi, Qian
    Ferraro, Danielle Angela
    Meyers, Jeffrey P.
    Saltz, Leonard
    Goldberg, Richard
    Van Cutsem, Eric
    Hurwitz, Herbert
    Fuchs, Charles
    Bokemeyer, Carsten
    Sargent, Daniel J.
    De Gramont, Aimery
    Price, Timothy Jay
    Adams, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Prognostic value of isolated peritoneal versus other metastatic sites in colorectal cancer (CRC) patients treated by systemic chemotherapy: Findings from 9,265 pts in the ARCAD database.
    Franko, Jan
    Shi, Qian
    Meyers, Jeffrey P.
    Heinemann, Volker
    Falcone, Alfredo
    Tebbutt, Niall C.
    Maughan, Tim
    Seymour, Matthew
    Saltz, Leonard
    Tournigand, Christophe
    Diaz-Rubio, Eduardo
    Sougklakos, Ioannis
    Chibaudel, Benoist
    Moen, Joseph
    De Gramont, Aimery
    Adams, Richard A.
    Sargent, Daniel J.
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [6] Characteristics of patients (pts) and prognostic factors across treatment lines (TL) in metastatic colorectal cancer (mCRC): An analysis from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
    Bachet, Jean-Baptiste
    Chibaudel, Benoist
    Rakez, Manel
    Goldberg, Richard M.
    Tebbutt, Niall C.
    Van Cutsem, Eric
    Haller, Daniel G.
    Hecht, J. Randolph Randolph
    Mayer, Robert J.
    Lichtman, Stuart M.
    Benson, Al
    Sobrero, Alberto F.
    Tabernero, Josep
    Adams, Richard
    Zalcberg, John Raymond
    Grothey, Axel
    Yoshino, Takayuki
    Shi, Qian
    De Gramont, Aimery
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Circulating tumor DNA (ctDNA) heterogeneity as first- and third-line treatment in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab
    Parseghian, Christine Megerdichian
    Beutner, Karl
    Boedigheimer, Michael
    Ruff, Paul
    Price, Timothy Jay
    Kim, Tae Won
    Fakih, Marwan
    Ang, Agnes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [8] Early predictors of prolonged overall survival (OS) in patients (pts) on first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): An ARCAD study with individual patient data (IPD) on 10,962 pts.
    Sommeijer, Dirkje Willemien
    Shi, Qian
    Saad, Everardo D.
    Coart, Elisabeth
    Buyse, Marc E.
    Burzykowski, Tomasz
    Meyers, Jeffrey P.
    Maughan, Tim
    Adams, Richard A.
    Seymour, Matthew T.
    Saltz, Leonard
    Goldberg, Richard M.
    Douillard, Jean-Yves
    Schmoll, Hans-Joachim
    Punt, Cornelis J. A.
    Tournigand, Christophe
    Chibaudel, Benoist
    De Gramont, Aimery
    Sargent, Daniel J.
    Zalcberg, John Raymond
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] The impact of late-line treatment on overall survival (OS) from the initiation of first-line chemotherapy (CT) for patients (pts) with metastatic colorectal cancer (mCRC)
    Kawakami, T.
    Masuishi, T.
    Kawamoto, Y.
    Go, H.
    Shirasu, H.
    Kato, K.
    Kumanishi, R.
    Sawada, K.
    Yamamoto, K.
    Yuki, S.
    Komatsu, Y.
    Yasui, H.
    Muro, K.
    Yamanaka, T.
    Yamazaki, K.
    ANNALS OF ONCOLOGY, 2019, 30 : 222 - 222
  • [10] Surgery with curative intent in patients (pts) treated with first-line chemotherapy (CT) plus bevacizumab (BEV) for metastatic colorectal cancer (mCRC): First BEAT and NO16966
    Cassidy, J.
    Cunningham, D.
    Berry, S. R.
    Rivera, F.
    Clarke, S. J.
    Kretzschmar, A.
    Diaz-Rubio, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345